MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?
Chilkoti, G., Gondode, P., Tiwari, S. (2021). MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?. EKB Journal Management System, 13(1), -. doi: 10.1186/s42077-021-00148-4
Geetanjali T. Chilkoti; Prakash G. Gondode; Spriha S. Tiwari. "MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?". EKB Journal Management System, 13, 1, 2021, -. doi: 10.1186/s42077-021-00148-4
Chilkoti, G., Gondode, P., Tiwari, S. (2021). 'MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?', EKB Journal Management System, 13(1), pp. -. doi: 10.1186/s42077-021-00148-4
Chilkoti, G., Gondode, P., Tiwari, S. MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?. EKB Journal Management System, 2021; 13(1): -. doi: 10.1186/s42077-021-00148-4

MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?

Ain-Shams Journal of Anesthesiology
Volume 13, Issue 1, January 2021  XML PDF (378.02 K)
DOI: 10.1186/s42077-021-00148-4
View on SCiNiTO View on SCiNiTO
Authors
Geetanjali T. Chilkoti; Prakash G. Gondode email orcid ; Spriha S. Tiwari
Statistics
Article View: 6
PDF Download: 19